Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05148936 · ClinicalTrials.gov registry record · NA

Communities Fighting COVID-19!

A NA study of Covid19, sponsored by San Diego State University.

Completed
Registry status
NA
Development phase
32,750
Enrollment target
1
Study location

NCT05148936 is a NA study of Covid19 that has completed, run by San Diego State University. The registered enrollment target is 32,750 participants, above the 2,354-participant average among 94 other Covid19 trials with a reported enrollment target (1291% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05148936, a NA study of Covid19, has completed, sponsored by San Diego State University.

COMPLETED
Registry status
NA
Development phase
32,750 participants
Enrollment target
1
Study location

Study Summary

To create and evaluate effective COVID-19 testing uptake strategies that focus on underserved individuals who are exposed but have not accessed testing, and underserved individuals who are not routinely tested because they are unaware of their exposure or risk status in order to increase testing among these populations and reduce Covid-19 related disparities.

Conditions Studied

Interventions

  • OTHER COVID-19 Testing Home-based (Aim 1)
  • OTHER COVID-19 Testing Mobile (Aim 1)
  • OTHER COVID-19 Testing Mobile Approach 1 (Aim 2)
  • OTHER COVID-19 Testing Mobile Approach 2 (Aim 2)

Study Locations (1)

California

  • Contact Households - San Diego

Trial Details

FieldValue
Enrollment Target 32,750 participants
Start Date 2020-10-25
Est. Completion 2023-08-25
Phase NA

Sponsor

San Diego State University

118 total trials

What the Registry Record Tells You About NCT05148936

The ClinicalTrials.gov registry entry for NCT05148936 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32,750 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,354-participant average among 94 other Covid19 trials with a reported enrollment target (1291% higher). The listed sponsor is San Diego State University, which has 118 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Covid19 appearing as the primary indexed condition, and to 4 interventions - of which COVID-19 Testing Home-based (Aim 1) is the first listed.

NCT05148936 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05148936 about?

NCT05148936 is a clinical study titled "Communities Fighting COVID-19!". To create and evaluate effective COVID-19 testing uptake strategies that focus on underserved individuals who are exposed but have not accessed testing, and underserved individuals who are not routinely tested because they are unaware of their exposure or risk status in order to increase testing amo...

What is the current status of trial NCT05148936?

This trial is currently completed. It is a NA study. The enrollment target is 32,750 participants. The study started on 2020-10-25. Estimated completion is 2023-08-25.

What conditions does trial NCT05148936 study?

This clinical trial studies the following conditions: Covid19.

What interventions are being tested in trial NCT05148936?

The interventions under investigation include: COVID-19 Testing Home-based (Aim 1) (OTHER), COVID-19 Testing Mobile (Aim 1) (OTHER), COVID-19 Testing Mobile Approach 1 (Aim 2) (OTHER), COVID-19 Testing Mobile Approach 2 (Aim 2) (OTHER).

Who is sponsoring clinical trial NCT05148936?

This trial is sponsored by San Diego State University, which has 118 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05148936 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Covid19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.